Abalos Therapeutics
Abalos Therapeutics is a viral Immuno-Oncology Treatment founded in 2005.
4
Funding Rounds
$69.0m
Money raised
Overview
Abalos Therapeutics is a viral Immuno-Oncology Treatment founded in 2005.
-
Website:
- Business model: B2B
- Headquarters: Essen
- Social accounts:
Funding
Funding series
Funding Series Analysis
The company Abalos Therapeutics has raised a total of $69m in funding over 4 rounds.
Key Insights:
- Abalos Therapeutics Series A round, October 2021: $43m
- Abalos Therapeutics October 2019 Series A Funding Round: $13m
- Abalos Therapeutics October 2019 Series A Funding Round: $13m
Abalos Therapeutics Series A round, October 2021
$43m
Abalos Therapeutics October 2019 Series A Funding Round
$13m
Abalos Therapeutics October 2019 Series A Funding Round
$13m
Industries
Abalos Therapeutics is active in the following industries: